Readers' Comments

Article: Bevacizumab for breast cancer: FDA grants a stay of execution Back to article | View all comments

Author: Dr. Alberto De la Guerra | January 19, 2011

Reader comments on this article are listed below. Review our comments policy.

You must be logged in to post a comment. Please log in or sign up for a free account.

Join the Doctors Lounge online medical community

Editorial activities: Publish, peer review, edit online articles.
Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.